CD79A and diffuse large B-cell lymphoma: Concerning the pathological subtype, the vast majority of PCNSLs (>95%) are diffuse large B-cell lymphomas (DLBCLs), expressing B-cell markers such as CD20, CD19, CD79a, and immunoglobulin light chains.